Do Not Use Advertised Brain Supplements
For a healthy 75-year-old man seeking cognitive enhancement with minimal side effects, I strongly recommend against using advertised brain supplements including ginkgo biloba, phosphatidylserine, huperzine A, bacopa, vinpocetine, or rhodiola. The highest-quality guideline evidence explicitly advises against their use for cognitive improvement in older adults.
Guideline Evidence Is Clear
The 2015 ESPEN Guidelines on Nutrition in Dementia provide the most authoritative framework here 1. While these guidelines focus on dementia patients, they establish a critical principle: they do not recommend any nutritional products for correction of cognitive impairment or prevention of cognitive decline (Statement 14, strong recommendation) 1. This includes omega-3 fatty acids, B vitamins, vitamin E, selenium, and other supplements commonly marketed for brain health 1.
The guideline's systematic rejection of supplements for cognitive enhancement applies even more strongly to your patient—a cognitively intact 75-year-old—since the evidence shows no benefit even in populations with established cognitive impairment.
Research Evidence Confirms Lack of Efficacy
The most rigorous research supports this recommendation:
A 2007 randomized controlled trial of ginkgo biloba (with phosphatidylserine and DHA) in healthy, cognitively intact older adults found no improvement in cognitive function or quality of life compared to placebo 2. Notably, one of six cognitive tests actually favored placebo over the supplement 2.
A 1998 study showed minimal objective benefit, with only one visual memory test showing modest improvement, while other cognitive measures showed no difference 3.
Even the most recent 2026 study combining ginkgo biloba with phosphatidylserine showed only "modest" and "visually consistent trends" rather than clinically meaningful improvements 4.
Safety Concerns Cannot Be Ignored
While proponents claim these supplements are "natural" and therefore safe, the evidence reveals concerning risks:
Drug Interactions: Ginkgo biloba has documented significant interactions with medications, particularly warfarin 5. A 2010 systematic review confirmed multiple drug interaction risks that "can place individual patients at great risk" 6.
Cutaneous Reactions: Fixed drug eruptions, contact dermatitis, and potentially Stevens-Johnson syndrome have been reported with ginkgo biloba 7. Vinpocetine causes facial erythema 7.
Lack of FDA Regulation: These supplements are not FDA-regulated for efficacy or safety 8. The 2026 review emphasizes "limited long-term studies evaluating safety and efficacy, especially in older adults" 8.
The Regulatory Reality
The FDA drug label information provided for phosphatidylserine 9 and huperzine A 10 are actually mislabeled—these are not FDA-approved drugs but rather dietary supplements that don't undergo the same rigorous testing. The huperzine A label appears to be confused with hydroxyzine (an antihistamine), highlighting the confusion and lack of standardization in this supplement space.
Clinical Bottom Line
Your 75-year-old patient has above-average cognitive function for his age (as demonstrated in the study population 2). There is:
- No evidence these supplements improve cognition in healthy older adults
- Documented safety concerns including drug interactions and adverse reactions
- Strong guideline recommendations against their use
- No FDA oversight ensuring quality, purity, or accurate labeling
The risk-benefit ratio clearly favors avoiding these supplements entirely. Instead, focus on evidence-based strategies: regular physical exercise, social engagement, Mediterranean diet, cardiovascular risk factor management, and adequate sleep—interventions with proven cognitive benefits and established safety profiles.